EPF's reaction to the draft reports on the revision of EU pharmaceutical legislation
Read EPF's reaction to the draft reports on the revision of the EU pharmaceutical legislation.
The European Patients’ Forum (EPF) welcomes the publication of the draft negotiating positions, bringing the legislative process one step closer to the adoption of the revision of the EU pharmaceutical legislation. The patient community has been waiting a long time for this crucial revision, which will have an impact on their access to safe, effective and high-quality medicines, as well as on their involvement in the lifecycle of medicines.
Read our reaction here.